Dr Theingi Aung
I did my postgraduate training in diabetes and endocrinology at the Oxford Deanery (2005-2014). I have a research interest in diabetes and cardiovascular disease and spent three and a half years during training running large scale clinical trials including ASCEND (A Study of Cardiovascular Events in Diabetes) and heart protection studies (HPS-2 Thrive and HPS-3 Reveal) at the clinical trial service unit (CTSU), the University of Oxford. I did my three year clinical research fellowship (2010-2013) at the CTSU investigating the cardiovascular disease (CVD) and diabetes, focusing on the role of aspirin and omega-3 fatty acid in the primary prevention of CVD in diabetes.
I joined the Department of Diabetes and Endocrinology at the Royal Berkshire Hospital in 2014 to lead and shape the new services, including the weight loss and bariatric services, and the integrated diabetes and endocrinology services. I am leading bariatric MDT clinics and weight loss bariatric care pathway, the VLCD weight loss project, various endocrine clinics including the virtual thyroid clinics and the radio-iodine treatment for benign thyroid disease.
I do various specialist clinics on different endocrine conditions including PCOS, parathyroid, adrenal and pituitary disorders and diabetes.
Some of the principal treatments carried out by Dr Theingi Aung at Spire include:
Endocrinology and diabetes
Spire Dunedin Hospital is only able to provide Covid-19 tests to patients undergoing surgery at our hospital. Covid-19 testing or antibody tests are not available as a standalone service.
Royal College of Physicians
Member of Association of British Clinical Diabetologist (ABCD)
Association for the Study of Obesity
Principal investigator of diabetes trials.
Consultant Physician and Endocrinologist, Royal Berkshire Hospital NHS Trust.